Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21
Elutia (Nasdaq: ELUT) announced that Dr. Randy Mills, President and CEO, will present at the LD Micro Main Event XIX in San Diego on Tuesday, October 21, 2025 at 1:00 p.m. PT (4:00 p.m. ET).
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Elutia (Nasdaq: ELUT) announced that Dr. Randy Mills, President and CEO, will present at the LD Micro Main Event XIX in San Diego on Tuesday, October 21, 2025 at 1:00 p.m. PT (4:00 p.m. ET).
A live webcast will be available and Elutia management will hold 1x1 investor meetings. Institutional investors may schedule meetings via an LD Micro representative or by emailing IR@elutia.com.
Details
News Market Reaction – ELUT
On Oct 15, the first trading day after this news, ELUT closed 0.87% above the previous close.
Data tracked by StockTitan Argus for the Oct 15 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
GAITHERSBURG, Md., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, President and Chief Executive Officer, will present at the LD Micro Main Event XIX Conference in San Diego on Tuesday, October 21, 2025, at 1:00 p.m. PT (4:00 p.m. ET).
LD Micro Main Event XIX Conference
Presentation Date: Tuesday, October 21, 2025
Presentation Time: 1:00 p.m. PT (4:00 p.m. ET)
Webcast: Click here
Elutia management will also participate in 1x1 investor meetings. Institutional investors interested in scheduling a meeting may contact an LD Micro representative or email IR@elutia.com.
About Elutia
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.
Investors:
Matt Steinberg
FINN Partners
matt.steinberg@finnpartners.com
This press release was published by a CLEAR® Verified individual.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.